Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1994. Start Trial.
Date Value
December 31, 2025 767.63M
December 31, 2024 757.36M
December 31, 2023 751.32M
December 31, 2022 623.76M
December 31, 2021 603.81M
December 31, 2020 717.29M
December 31, 2019 537.41M
December 31, 2018 193.82M
December 31, 2017 173.76M
December 31, 2016 141.78M
December 31, 2015 71.77M
December 31, 2014 58.45M
December 31, 2013 61.62M
December 31, 2012 40.06M
December 31, 2011 26.59M
March 31, 2011
March 31, 2010 53.13M
Date Value
March 31, 2009 48.86M
March 31, 2008 49.78M
March 31, 2007 22.63M
March 31, 2006 18.88M
March 31, 2005 17.21M
March 31, 2004 13.95M
March 31, 2003 15.52M
March 31, 2002 20.84M
March 31, 2001 23.94M
March 31, 2000 34.03M
March 31, 1999 3.251M
March 31, 1998 4.726M
March 31, 1997 3.538M
March 31, 1996 7.222M
March 31, 1995 15.30M
March 31, 1994 29.22M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
BioLife Solutions, Inc. 88.93M
Anika Therapeutics, Inc. 57.48M
Danaher Corp. 4.615B
Liquidia Corp. 190.68M
Harmony Biosciences Holdings, Inc. 775.34M